Determination of mildronate in human plasma and urine by liquid chromatography–tandem mass spectrometry
Authors:
- 3 January 2007
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 852 (1-2) , 35-39
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Mildronate Cardioprotective Action through Carnitine-Lowering EffectTrends in Cardiovascular Medicine, 2002
- Bioanalytical Method Validation—A Revisit with a Decade of ProgressPharmaceutical Research, 2000
- Pharmacokinetics and Biological Fate of 3-(2,2,2-Trimethylhydrazinium)Propionate Dihydrate (MET-88), a Novel Cardioprotective Agent, in RatsDrug Metabolism and Disposition, 2000
- Effects of MET-88, a .GAMMA.-Butyrobetaine Hydroxylase Inhibitor, on Tissue Carnitine and Lipid Levels in Rats.Biological and Pharmaceutical Bulletin, 2000
- Determination of pramipexole (U-98,528) in human plasma by high-performance liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- HPLC analysis of mildronate and its analogues in plasmaJournal of Pharmaceutical and Biomedical Analysis, 1993
- Analysis of acylcarnitines in normal human urine with the radioisotopic exchange-high performance liquid chromatography (HPLC) methodClinica Chimica Acta, 1989